Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma ; volume:70 ; number:6 ; day:2 ; month:1 ; year:2021 ; pages:1705-1719 ; date:6.2021
Cancer immunology immunotherapy ; 70, Heft 6 (2.1.2021), 1705-1719, 6.2021
- Urheber
-
Yi, Ming
Li, Anping
Zhou, Linghui
Chu, Qian
Luo, Suxia
Wu, Kongming
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-020-02817-z
- URN
-
urn:nbn:de:101:1-2021091919014563016480
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yi, Ming
- Li, Anping
- Zhou, Linghui
- Chu, Qian
- Luo, Suxia
- Wu, Kongming
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Neurotoxicities associated with immune checkpoint inhibitor therapy
Immune checkpoint inhibitor induced neurocognitive deficits in patients
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Neurotoxicities associated with immune checkpoint inhibitor therapy
Immune checkpoint inhibitor induced neurocognitive deficits in patients
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Neurotoxicities associated with immune checkpoint inhibitor therapy